跳至主要内容
临床试验/JPRN-UMIN000012559
JPRN-UMIN000012559已完成2 期

The pilot study on surgical safety after neoadjuvant chemotherapy of mFOLFOX6 for locally advanced rectal cancer. - The pilot study on surgical safety after neoadjuvant chemotherapy for locally advanced rectal cancer.

Gastroenterological Surgery I, Hokkaido University Graduate School of Medicine0 个研究点目标入组 41 人开始时间: 2013年12月14日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
41

研究概览

简要总结

Surgical morbidity (grade 3 or above) occurred in 4 patients (10.5%). Surgery after four courses of mFOLFOX6 chemotherapy can be a safe and promising strategy for patients with locally advanced rectal cancer.

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 75years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Double cancer 2. Pregnant or lactating women. 3. Patients with a history of colorectal cancer(Excluding mucosal cancer). 4. Patients with peripheral sensory neuropathy(CTCAE v4.0> Grade 1). 5. Patients with infectious disease requiring systemic therapy. 6. Patients with uncontrolable cardiovascular disease. 7. Patients with a history of mental disorder.

研究者

发起方
Gastroenterological Surgery I, Hokkaido University Graduate School of Medicine

相似试验